Who we are…
As medical supplier consultants, we work with medical device manufacturers to help them make informed business decisions, turn those decisions into actionable strategies, and implement them efficiently. Our services allow manufacturers to focus on developing innovative medical devices instead of spending time searching for distributors, negotiating contracts, or navigating complex FDA regulations and market requirements
We collaborate with numerous international medical device brands to support their entry into the United States medical device market. Every strategy we develop is customized for each client’s product and based on extensive research and analysis. During this process, we evaluate the product’s specialty, analyze key market indicators to forecast growth potential, and identify the most effective target customers and distribution channels.
What our customers say
RIM Medical Technologies
Dawa provides the best quality of service. Their response is always quick and efficient. We would definitely highly recommend Dawa as initial importer, US agent and warehouse provider and are grateful to Dawa team and Stéphan Toupin for their great work.
iLine Microsystems S.L.
We are very satisfied with the support provided by Dawa Medical. Any issue is resolved in a timely manner.
Momentis Surgical
Great Business Partner. Professional and on-time support!
Thank you!
Momentis Surgical LTD.
Great responsiveness and support. Whenever there is unexpected issue that requires advice or action DAWA's team is there to assist.
Latest news
The Access Brief No. 9: Medical Device Tariffs, FDA Guidance & Hospital Payment Cuts
[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” row_position_desktop=”default” row_position_tablet=”inherit” row_position_phone=”inherit” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column…
The Access Brief No. 8: FDA Renewals, Medicare Payments & Import Tariff Risks
[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” row_position_desktop=”default” row_position_tablet=”inherit” row_position_phone=”inherit” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column…
The Access Brief No. 7: FDA Fees, Device Alerts & Canada Trade Risks
[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” row_position_desktop=”default” row_position_tablet=”inherit” row_position_phone=”inherit” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column…
The Access Brief No. 6: VA Market Access, FDA Pathways & Supply Chain Rules
[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” row_position_desktop=”default” row_position_tablet=”inherit” row_position_phone=”inherit” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column…
The Access Brief No. 5: Device Recalls, Cybersecurity & Canada Tariff Relief
[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” row_position_desktop=”default” row_position_tablet=”inherit” row_position_phone=”inherit” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column…
The Access Brief No. 4: FDA Recalls, Supply Chain Risks & Import Updates
[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” row_position_desktop=”default” row_position_tablet=”inherit” row_position_phone=”inherit” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column…